April 4, 2020

Electrophoresis Equipment And Supplies Market was Valued at US$ 1,729.2 Mn in 2017

The latest market report published by Credence Research, Inc. “Electrophoresis Equipment and Supplies Market Growth, Future Prospects, and Competitive Analysis, 2018–2026” the electrophoresis equipment and supplies market was valued at US$ 1,729.2 Mn in 2017 and projected to reach US$ 2,554.4 Mn by 2026 at a CAGR of 4.4% over the forecast period from 2018 to 2026.

You can get the sample copy of this research by Credence Research here 

Market Insights

The market for electrophoresis equipment and supplies is likely to have a noticeable CAGR during the forecast period from 2018 to 2026. Electrophoresis is a technique most commonly used in the lab to separate charged particles or molecules such as deoxyribonucleic acid (DNA) by size. Electrophoresis detects and quantifies minute traces of a wide range of biomolecules in a mixture including nucleic acids, proteins, carbohydrates and amino acids. The technique separates DNA fragments and other macromolecules, in particular proteins and nucleic acids such as ribonucleic acid (RNA), and is widely used by life science laboratories for protein analysis and separation.

Market variables are rising global prevalence of cancer, genetic disorders, and infectious diseases, increasing research activities coupled with funding in the field of proteomics and genomics, increasing numbers of industry-academic research institute partnerships, and increasing focus on next-generation sequencing (NGS) research activities. A paradigm shift from genomics to proteomics is more beneficial, as proteins are functional molecules in cells and represent real conditions, leading to increasing applications in cancer research.New technologies make it possible to carry out a comprehensive analysis of genomes, proteomes and transcriptomes in the field of health and disease by helping cancer research activities.

You can get the sample copy of this research by Credence Research here 

Major players in this space are Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc.; GE Healthcare; Agilent Technologies, Inc.; Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation); PerkinElmer Inc.; Shimadzu Corporation; Merck KGaA; QIAGEN; and Helena Laboratories. Improved technology, advanced solutions, wide-ranging product portfolio, and well-organized post-sales services are the factors supporting the dominance of these market players.

The gradual increase in the number of new entrants makes the environment highly competitive and competitive at a higher level. Two-dimensional gel electrophoresis (2DE) is widely used in biomarker discovery for proteome fractionation and separation in biological samples, thus promoting market growth.

Electrophoresis Equipment And Supplies Market

Browse Full Report Originally Published by Credence Research 

Key Market Movements:

  • Globally, the electrophoresis equipment and supplies market will witness a considerable growth at a CAGR of 4.4% over the forecast period from 2018 to 2026
  • Capillary electrophoresis technique is on the rise due to the growth in hyphenated technology, which in turn increasing the adoption of capillary electrophoresis–mass spectrometry (CE-MS). Researchers often use this technique owing to its higher efficiency & resolution, minimum sample & solvent requirements, and on-line detection principle.
  • The research & diagnostics segment held the lion’s share of the market in 2017 due to growing applications of electrophoresis in drug discovery, mounting technological advancements such as automated electrophoresis systems and microchip-based CE diagnostics
  • North America would lead the market throughout the forecast period. This is owing to the presence of key market participants & developed healthcare infrastructure, increasing focus of stakeholders on research projects involving proteins, genes, and biomolecules (nucleic acids, carbohydrates, and amino acids), and rising research activities pertaining to genomics and proteomics in the U.S. and Canada.
  • Asia Pacific is likely to witness comparatively higher market growth rate from 2018 to 2026 due to the presence of robust healthcare research infrastructure & raw materials and reagents manufacturers. Additionally, patent expiries of several drugs are triggering pharmaceutical manufacturers to discover & develop novel or innovative drugs are expected to support the market growth.

Leave a Reply

Your email address will not be published. Required fields are marked *